I’m no Joe Papa fan, but Joe Papa isn’t in charge anymore. Our supply problems have been ongoing and the second Saunders takes over our nice, new, lean, low debt spin off, he literally spends half a year of our total revenue on a fucking drop months before we’re about to launch another one. That’s stupid and short sighted.
If your pipeline is dry, you invest in R&D. You take the time to build it up. Instead, we invested about as much in R&D as we got taxed last year (which was only $10 million on $4 billion of revenue). There’s nothing innovative about Miebo or anything we’re selling. Moving billions of dollars around in a company that just was in serious debt to soften the launch of your shitty Epipen 2.0 price gouging drug instead of fixing backorders that have crippled Vision Care and Surgical (which makes up 75% of the company’s annual revenue) is in my opinion very stupid. Saunders is just looking to fatten the cow before selling off parts of it out of necessity. Then he’ll use the sell off to further brand himself as a “deal maker” when really he is doing nothing unique, smart or focused at all.
